SCHEMBL6859760

SCHEMBL6859760

CC(C)(O)c1ccc2c(c1)C(=CCCBr)C1=CC=CCN1CO2

nearest known ligand 0.34

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ CCR1 P32246 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6859678 0.78 CCR1 (0.35) CCR1
SCHEMBL6859353 0.77 CCR1 (0.41) CCR1
SCHEMBL436923 0.70 CCR1 (0.59) CCR1
SCHEMBL436922 0.70 CCR1 (0.59) CCR1
SCHEMBL1322545 0.66 — —
SCHEMBL1322548 0.66 — —
SCHEMBL14420192 0.61 CCR1 (0.32) CCR1
SCHEMBL14579805 0.60 CCR1 (0.59) CCR1
SCHEMBL18633827 0.60 CCR1 (0.39) CCR1
SCHEMBL12121948 0.59 CCR1 (0.68) CCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1448566-A2 CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2004-08-25 — — EP disclosed
WO-2003045942-A2 CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2003-06-05 — — WO disclosed
Send feedback